25 XP   0   0   10

ChemoMetec A/S
Buy, Hold or Sell?

Let's analyse Chemometec together

PenkeI guess you are interested in ChemoMetec A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ChemoMetec A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ChemoMetec A/S

I send you an email if I find something interesting about ChemoMetec A/S.

Quick analysis of Chemometec (30 sec.)










What can you expect buying and holding a share of Chemometec? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
kr30.63
Expected worth in 1 year
kr71.05
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
kr40.42
Return On Investment
14.1%

For what price can you sell your share?

Current Price per Share
kr286.40
Expected price per share
kr255.00 - kr389.00
How sure are you?
50%

1. Valuation of Chemometec (5 min.)




Live pricePrice per Share (EOD)

kr286.40

Intrinsic Value Per Share

kr40.42 - kr110.33

Total Value Per Share

kr71.05 - kr140.96

2. Growth of Chemometec (5 min.)




Is Chemometec growing?

Current yearPrevious yearGrowGrow %
How rich?$76.1m$51m$25.1m33.0%

How much money is Chemometec making?

Current yearPrevious yearGrowGrow %
Making money$25.5m$22.7m$2.7m10.7%
Net Profit Margin40.2%37.2%--

How much money comes from the company's main activities?

3. Financial Health of Chemometec (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Chemometec? (5 min.)

Welcome investor! Chemometec's management wants to use your money to grow the business. In return you get a share of Chemometec.

What can you expect buying and holding a share of Chemometec?

First you should know what it really means to hold a share of Chemometec. And how you can make/lose money.

Speculation

The Price per Share of Chemometec is kr286.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chemometec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chemometec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr30.63. Based on the TTM, the Book Value Change Per Share is kr10.10 per quarter. Based on the YOY, the Book Value Change Per Share is kr5.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chemometec.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps1.470.5%1.470.5%1.310.5%0.870.3%0.470.2%
Usd Book Value Change Per Share1.440.5%1.440.5%0.760.3%0.750.3%0.400.1%
Usd Dividend Per Share0.000.0%0.000.0%0.570.2%0.970.3%0.710.2%
Usd Total Gains Per Share1.440.5%1.440.5%1.330.5%1.720.6%1.110.4%
Usd Price Per Share66.54-66.54-108.10-72.53-38.38-
Price to Earnings Ratio45.39-45.39-82.61-90.50-73.72-
Price-to-Total Gains Ratio46.12-46.12-81.40-63.91-60.27-
Price to Book Ratio15.21-15.21-36.88-30.08-19.20-
Price-to-Total Gains Ratio46.12-46.12-81.40-63.91-60.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share40.89792
Number of shares24
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.97
Usd Book Value Change Per Share1.440.75
Usd Total Gains Per Share1.441.72
Gains per Quarter (24 shares)34.6341.30
Gains per Year (24 shares)138.52165.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101391299372155
20277268185145320
30416407278217485
40554546371290650
50693685464362815
60831824556435980
709709636495071145
80110811027425801310
90124712418346521475
100138513809277251640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.03.00.084.2%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.03.00.084.2%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%6.00.04.060.0%6.00.013.031.6%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.03.00.084.2%

Fundamentals of Chemometec

About ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. In addition, the company provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Fundamental data was last updated by Penke on 2024-04-20 20:42:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of ChemoMetec A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chemometec earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • A Net Profit Margin of 40.2% means that kr0.40 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ChemoMetec A/S:

  • The MRQ is 40.2%. The company is making a huge profit. +2
  • The TTM is 40.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ40.2%TTM40.2%0.0%
TTM40.2%YOY37.2%+3.0%
TTM40.2%5Y32.1%+8.1%
5Y32.1%10Y21.3%+10.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ40.2%-11.2%+51.4%
TTM40.2%-18.9%+59.1%
YOY37.2%-13.9%+51.1%
5Y32.1%-21.0%+53.1%
10Y21.3%-24.6%+45.9%
1.1.2. Return on Assets

Shows how efficient Chemometec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • 27.2% Return on Assets means that Chemometec generated kr0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ChemoMetec A/S:

  • The MRQ is 27.2%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 27.2%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ27.2%TTM27.2%0.0%
TTM27.2%YOY31.8%-4.7%
TTM27.2%5Y24.9%+2.2%
5Y24.9%10Y17.5%+7.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ27.2%-4.0%+31.2%
TTM27.2%-4.6%+31.8%
YOY31.8%-4.4%+36.2%
5Y24.9%-3.9%+28.8%
10Y17.5%-4.9%+22.4%
1.1.3. Return on Equity

Shows how efficient Chemometec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • 33.5% Return on Equity means Chemometec generated kr0.34 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ChemoMetec A/S:

  • The MRQ is 33.5%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 33.5%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ33.5%TTM33.5%0.0%
TTM33.5%YOY44.6%-11.1%
TTM33.5%5Y33.0%+0.6%
5Y33.0%10Y24.0%+9.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ33.5%-4.1%+37.6%
TTM33.5%-5.7%+39.2%
YOY44.6%-5.5%+50.1%
5Y33.0%-6.0%+39.0%
10Y24.0%-6.9%+30.9%

1.2. Operating Efficiency of ChemoMetec A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chemometec is operating .

  • Measures how much profit Chemometec makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • An Operating Margin of 52.1% means the company generated kr0.52  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ChemoMetec A/S:

  • The MRQ is 52.1%. The company is operating very efficient. +2
  • The TTM is 52.1%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ52.1%TTM52.1%0.0%
TTM52.1%YOY47.8%+4.3%
TTM52.1%5Y41.5%+10.6%
5Y41.5%10Y27.2%+14.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ52.1%-24.1%+76.2%
TTM52.1%-16.7%+68.8%
YOY47.8%-12.5%+60.3%
5Y41.5%-19.0%+60.5%
10Y27.2%-23.8%+51.0%
1.2.2. Operating Ratio

Measures how efficient Chemometec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.48 means that the operating costs are kr0.48 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.481. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.481. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.481TTM0.4810.000
TTM0.481YOY0.527-0.046
TTM0.4815Y0.585-0.104
5Y0.58510Y0.728-0.143
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4811.431-0.950
TTM0.4811.426-0.945
YOY0.5271.435-0.908
5Y0.5851.436-0.851
10Y0.7281.373-0.645

1.3. Liquidity of ChemoMetec A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chemometec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 4.13 means the company has kr4.13 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of ChemoMetec A/S:

  • The MRQ is 4.133. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.133. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.133TTM4.1330.000
TTM4.133YOY2.569+1.564
TTM4.1335Y3.289+0.845
5Y3.28910Y2.958+0.330
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1332.726+1.407
TTM4.1332.732+1.401
YOY2.5693.496-0.927
5Y3.2893.560-0.271
10Y2.9583.507-0.549
1.3.2. Quick Ratio

Measures if Chemometec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • A Quick Ratio of 3.12 means the company can pay off kr3.12 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ChemoMetec A/S:

  • The MRQ is 3.116. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.116. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.116TTM3.1160.000
TTM3.116YOY2.083+1.033
TTM3.1165Y2.645+0.471
5Y2.64510Y2.235+0.411
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1161.527+1.589
TTM3.1161.645+1.471
YOY2.0832.113-0.030
5Y2.6452.289+0.356
10Y2.2352.245-0.010

1.4. Solvency of ChemoMetec A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chemometec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chemometec to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.19 means that Chemometec assets are financed with 19.0% credit (debt) and the remaining percentage (100% - 19.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.190. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.190. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.1900.000
TTM0.190YOY0.287-0.098
TTM0.1905Y0.242-0.052
5Y0.24210Y0.268-0.026
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1900.393-0.203
TTM0.1900.386-0.196
YOY0.2870.337-0.050
5Y0.2420.442-0.200
10Y0.2680.461-0.193
1.4.2. Debt to Equity Ratio

Measures if Chemometec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chemometec to the Medical Devices industry mean.
  • A Debt to Equity ratio of 23.4% means that company has kr0.23 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ChemoMetec A/S:

  • The MRQ is 0.234. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.234. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.2340.000
TTM0.234YOY0.403-0.169
TTM0.2345Y0.322-0.088
5Y0.32210Y0.380-0.058
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2340.560-0.326
TTM0.2340.560-0.326
YOY0.4030.479-0.076
5Y0.3220.625-0.303
10Y0.3800.676-0.296

2. Market Valuation of ChemoMetec A/S

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Chemometec generates.

  • Above 15 is considered overpriced but always compare Chemometec to the Medical Devices industry mean.
  • A PE ratio of 45.39 means the investor is paying kr45.39 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ChemoMetec A/S:

  • The EOD is 27.896. Based on the earnings, the company is overpriced. -1
  • The MRQ is 45.389. Based on the earnings, the company is overpriced. -1
  • The TTM is 45.389. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD27.896MRQ45.389-17.493
MRQ45.389TTM45.3890.000
TTM45.389YOY82.610-37.220
TTM45.3895Y90.500-45.111
5Y90.50010Y73.722+16.778
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD27.896-0.992+28.888
MRQ45.389-1.592+46.981
TTM45.389-2.128+47.517
YOY82.610-2.756+85.366
5Y90.500-2.086+92.586
10Y73.722-1.490+75.212
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ChemoMetec A/S:

  • The EOD is 43.978. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 71.557. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 71.557. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD43.978MRQ71.557-27.579
MRQ71.557TTM71.5570.000
TTM71.557YOY108.924-37.367
TTM71.5575Y113.162-41.605
5Y113.16210Y-1.789+114.951
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD43.978-0.936+44.914
MRQ71.557-1.487+73.044
TTM71.557-2.933+74.490
YOY108.924-6.215+115.139
5Y113.162-4.622+117.784
10Y-1.789-4.718+2.929
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chemometec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 15.21 means the investor is paying kr15.21 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of ChemoMetec A/S:

  • The EOD is 9.350. Based on the equity, the company is overpriced. -1
  • The MRQ is 15.214. Based on the equity, the company is expensive. -2
  • The TTM is 15.214. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.350MRQ15.214-5.863
MRQ15.214TTM15.2140.000
TTM15.214YOY36.880-21.666
TTM15.2145Y30.078-14.864
5Y30.07810Y19.203+10.875
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD9.3501.923+7.427
MRQ15.2142.377+12.837
TTM15.2142.451+12.763
YOY36.8803.215+33.665
5Y30.0783.862+26.216
10Y19.2034.187+15.016
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ChemoMetec A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--10.10410.1040%5.300+91%5.287+91%2.815+259%
Book Value Per Share--30.63030.6300%20.526+49%17.599+74%10.438+193%
Current Ratio--4.1334.1330%2.569+61%3.289+26%2.958+40%
Debt To Asset Ratio--0.1900.1900%0.287-34%0.242-22%0.268-29%
Debt To Equity Ratio--0.2340.2340%0.403-42%0.322-27%0.380-38%
Dividend Per Share----0%4.000-100%6.763-100%4.944-100%
Eps--10.26710.2670%9.164+12%6.062+69%3.291+212%
Free Cash Flow Per Share--6.5126.5120%6.950-6%4.529+44%2.255+189%
Free Cash Flow To Equity Per Share--6.3446.3440%2.984+113%3.535+79%1.764+260%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--110.329--------
Intrinsic Value_10Y_min--40.421--------
Intrinsic Value_1Y_max--7.171--------
Intrinsic Value_1Y_min--2.736--------
Intrinsic Value_3Y_max--24.506--------
Intrinsic Value_3Y_min--9.407--------
Intrinsic Value_5Y_max--45.411--------
Intrinsic Value_5Y_min--17.329--------
Market Cap4984076000.000-63%8109565000.0008109565000.0000%13173692500.000-38%8838729750.000-8%4677548365.000+73%
Net Profit Margin--0.4020.4020%0.372+8%0.321+25%0.213+89%
Operating Margin--0.5210.5210%0.478+9%0.415+25%0.272+92%
Operating Ratio--0.4810.4810%0.527-9%0.585-18%0.728-34%
Pb Ratio9.350-63%15.21415.2140%36.880-59%30.078-49%19.203-21%
Pe Ratio27.896-63%45.38945.3890%82.610-45%90.500-50%73.722-38%
Price Per Share286.400-63%466.000466.0000%757.000-38%507.900-8%268.786+73%
Price To Free Cash Flow Ratio43.978-63%71.55771.5570%108.924-34%113.162-37%-1.789+102%
Price To Total Gains Ratio28.345-63%46.12046.1200%81.400-43%63.907-28%60.271-23%
Quick Ratio--3.1163.1160%2.083+50%2.645+18%2.235+39%
Return On Assets--0.2720.2720%0.318-15%0.249+9%0.175+55%
Return On Equity--0.3350.3350%0.446-25%0.330+2%0.240+40%
Total Gains Per Share--10.10410.1040%9.300+9%12.050-16%7.759+30%
Usd Book Value--76118397.60076118397.6000%51008874.000+49%43734384.960+74%25938648.960+193%
Usd Book Value Change Per Share--1.4431.4430%0.757+91%0.755+91%0.402+259%
Usd Book Value Per Share--4.3744.3740%2.931+49%2.513+74%1.491+193%
Usd Dividend Per Share----0%0.571-100%0.966-100%0.706-100%
Usd Eps--1.4661.4660%1.309+12%0.866+69%0.470+212%
Usd Free Cash Flow--16183524.00016183524.0000%17270803.200-6%11254867.680+44%5604628.680+189%
Usd Free Cash Flow Per Share--0.9300.9300%0.992-6%0.647+44%0.322+189%
Usd Free Cash Flow To Equity Per Share--0.9060.9060%0.426+113%0.505+79%0.252+260%
Usd Market Cap711726052.800-63%1158045882.0001158045882.0000%1881203289.000-38%1262170608.300-8%667953906.522+73%
Usd Price Per Share40.898-63%66.54566.5450%108.100-38%72.528-8%38.383+73%
Usd Profit--25513647.60025513647.6000%22772173.200+12%15065342.880+69%8179298.400+212%
Usd Revenue--63460462.80063460462.8000%61174234.800+4%44083302.480+44%27678195.720+129%
Usd Total Gains Per Share--1.4431.4430%1.328+9%1.721-16%1.108+30%
 EOD+4 -4MRQTTM+0 -0YOY+24 -115Y+27 -810Y+30 -5

3.2. Fundamental Score

Let's check the fundamental score of ChemoMetec A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.896
Price to Book Ratio (EOD)Between0-19.350
Net Profit Margin (MRQ)Greater than00.402
Operating Margin (MRQ)Greater than00.521
Quick Ratio (MRQ)Greater than13.116
Current Ratio (MRQ)Greater than14.133
Debt to Asset Ratio (MRQ)Less than10.190
Debt to Equity Ratio (MRQ)Less than10.234
Return on Equity (MRQ)Greater than0.150.335
Return on Assets (MRQ)Greater than0.050.272
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of ChemoMetec A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.350
Ma 20Greater thanMa 50360.730
Ma 50Greater thanMa 100425.730
Ma 100Greater thanMa 200401.007
OpenGreater thanClose288.200
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Net Interest Income  -693-449-1,142312-830-678-1,5082,8721,364



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in DKK. All numbers in thousands.

Summary
Total Assets657,976
Total Liabilities124,934
Total Stockholder Equity533,042
 As reported
Total Liabilities 124,934
Total Stockholder Equity+ 533,042
Total Assets = 657,976

Assets

Total Assets657,976
Total Current Assets492,661
Long-term Assets165,315
Total Current Assets
Cash And Cash Equivalents 316,571
Net Receivables 54,830
Inventory 112,635
Total Current Assets  (as reported)492,661
Total Current Assets  (calculated)484,036
+/- 8,625
Long-term Assets
Property Plant Equipment 82,685
Intangible Assets 79,663
Other Assets 2,967
Long-term Assets  (as reported)165,315
Long-term Assets  (calculated)165,315
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities119,191
Long-term Liabilities5,743
Total Stockholder Equity533,042
Total Current Liabilities
Short-term Debt 3,517
Short Long Term Debt 1,011
Accounts payable 17,550
Other Current Liabilities 101,641
Total Current Liabilities  (as reported)119,191
Total Current Liabilities  (calculated)123,719
+/- 4,528
Long-term Liabilities
Capital Lease Obligations 6,149
Long-term Liabilities  (as reported)5,743
Long-term Liabilities  (calculated)6,149
+/- 406
Total Stockholder Equity
Common Stock17,402
Retained Earnings 411,207
Other Stockholders Equity 104,433
Total Stockholder Equity (as reported)533,042
Total Stockholder Equity (calculated)533,042
+/-0
Other
Capital Stock17,402
Cash and Short Term Investments 316,571
Common Stock Shares Outstanding 17,402
Current Deferred Revenue-3,517
Liabilities and Stockholders Equity 657,976
Net Debt -309,411
Net Invested Capital 534,053
Net Tangible Assets 453,379
Net Working Capital 373,470
Property Plant and Equipment Gross 155,059
Short Long Term Debt Total 7,160



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-30
> Total Assets 
5,191
7,915
32,023
51,481
56,055
65,164
62,716
60,779
49,891
50,805
51,350
63,466
90,379
97,620
113,995
238,215
263,116
344,909
501,273
657,976
657,976501,273344,909263,116238,215113,99597,62090,37963,46651,35050,80549,89160,77962,71665,16456,05551,48132,0237,9155,191
   > Total Current Assets 
2,735
4,986
23,207
35,179
31,276
27,192
23,476
20,101
21,811
22,959
22,162
29,269
37,525
41,018
46,806
154,828
168,261
244,357
352,935
492,661
492,661352,935244,357168,261154,82846,80641,01837,52529,26922,16222,95921,81120,10123,47627,19231,27635,17923,2074,9862,735
       Cash And Cash Equivalents 
265
864
17,817
25,268
5,400
11,826
8,879
7,121
8,705
9,066
6,853
10,893
14,118
12,395
9,780
98,195
96,941
150,109
209,025
316,571
316,571209,025150,10996,94198,1959,78012,39514,11810,8936,8539,0668,7057,1218,87911,8265,40025,26817,817864265
       Net Receivables 
0
2,013
2,545
5,682
0
8,303
6,657
5,334
5,209
6,513
7,173
11,899
15,079
15,309
20,191
37,116
35,441
50,644
77,119
54,830
54,83077,11950,64435,44137,11620,19115,30915,07911,8997,1736,5135,2095,3346,6578,30305,6822,5452,0130
       Inventory 
719
2,109
2,845
4,229
5,520
6,805
7,911
7,605
7,850
7,371
8,113
6,476
7,544
13,314
16,835
19,517
25,112
30,113
66,790
112,635
112,63566,79030,11325,11219,51716,83513,3147,5446,4768,1137,3717,8507,6057,9116,8055,5204,2292,8452,109719
       Other Current Assets 
1,751
2,013
2,545
5,682
20,356
8,561
6,686
5,375
5,256
6,522
7,196
1
15,863
15,309
20,191
37,116
46,208
64,135
1
0
0164,13546,20837,11620,19115,30915,86317,1966,5225,2565,3756,6868,56120,3565,6822,5452,0131,751
   > Long-term Assets 
2,456
2,929
8,816
16,302
24,779
37,972
39,240
40,678
28,080
27,846
29,189
34,198
52,854
56,602
67,189
83,387
94,855
100,552
148,338
165,315
165,315148,338100,55294,85583,38767,18956,60252,85434,19829,18927,84628,08040,67839,24037,97224,77916,3028,8162,9292,456
       Property Plant Equipment 
1,395
2,122
1,546
2,927
3,971
5,365
4,587
3,276
1,854
1,146
1,666
5,498
25,474
26,424
28,938
38,145
43,361
42,496
74,783
82,685
82,68574,78342,49643,36138,14528,93826,42425,4745,4981,6661,1461,8543,2764,5875,3653,9712,9271,5462,1221,395
       Intangible Assets 
550
275
2,318
8,339
0
27,464
31,626
34,453
22,116
23,305
24,095
23,621
26,209
30,048
38,205
45,131
51,383
57,884
67,398
79,663
79,66367,39857,88451,38345,13138,20530,04826,20923,62124,09523,30522,11634,45331,62627,46408,3392,318275550
       Long-term Assets Other 
511
532
532
616
536
494
516
559
443
439
472
843
19
46
46
-83,276
-94,744
-100,380
-142,181
-162,348
-162,348-142,181-100,380-94,744-83,276464619843472439443559516494536616532532511
> Total Liabilities 
15,256
19,254
15,528
12,146
4,341
8,852
10,091
8,069
7,030
7,572
6,820
17,116
33,530
33,243
40,985
64,874
60,365
79,932
144,068
124,934
124,934144,06879,93260,36564,87440,98533,24333,53017,1166,8207,5727,0308,06910,0918,8524,34112,14615,52819,25415,256
   > Total Current Liabilities 
2,946
3,889
4,585
6,168
4,341
4,766
5,978
4,685
4,414
5,816
5,894
11,882
15,944
21,082
17,871
54,980
47,680
71,973
137,378
119,191
119,191137,37871,97347,68054,98017,87121,08215,94411,8825,8945,8164,4144,6855,9784,7664,3416,1684,5853,8892,946
       Short-term Debt 
510
0
0
2,797
0
577
3,463
729
768
786
828
2,599
4,883
9,909
1,703
18,795
1,101
1,446
1,934
3,517
3,5171,9341,4461,10118,7951,7039,9094,8832,5998287867687293,46357702,79700510
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
1,755
1,916
4,883
9,642
1,703
18,795
424
592
1,025
1,011
1,0111,02559242418,7951,7039,6424,8831,9161,7550000000000
       Accounts payable 
2,244
2,667
2,407
2,194
2,504
1,280
1,823
1,216
990
1,891
1,412
3,475
5,393
4,888
7,264
9,707
8,427
8,710
17,023
17,550
17,55017,0238,7108,4279,7077,2644,8885,3933,4751,4121,8919901,2161,8231,2802,5042,1942,4072,6672,244
       Other Current Liabilities 
192
1,222
2,178
3,371
1,837
2,909
692
3,956
3,646
3,139
1
5,808
155
6,285
8,904
45,273
39,253
63,263
120,355
101,641
101,641120,35563,26339,25345,2738,9046,2851555,80813,1393,6463,9566922,9091,8373,3712,1781,222192
   > Long-term Liabilities 
12,310
15,365
10,943
5,978
2,504
4,086
4,113
3,384
2,616
1,756
926
5,234
17,586
12,161
23,114
9,894
12,685
7,959
6,690
5,743
5,7436,6907,95912,6859,89423,11412,16117,5865,2349261,7562,6163,3844,1134,0862,5045,97810,94315,36512,310
       Other Liabilities 
0
430
278
103
0
0
0
0
0
0
0
0
240
216
4,711
9,894
11,495
7,047
1,830
2,100
2,1001,8307,04711,4959,8944,711216240000000001032784300
> Total Stockholder Equity
-10,065
-11,339
16,495
39,335
51,714
56,312
52,625
52,710
42,861
43,233
44,530
46,350
56,849
64,377
73,010
173,341
202,751
264,977
357,205
533,042
533,042357,205264,977202,751173,34173,01064,37756,84946,35044,53043,23342,86152,71052,62556,31251,71439,33516,495-11,339-10,065
   Common Stock
1,271
1,271
1,608
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,402
17,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,40217,4021,6081,2711,271
   Retained Earnings 
-11,336
-12,610
14,887
21,933
34,312
38,910
35,223
35,308
25,459
25,831
27,128
28,948
39,447
46,975
55,226
108,293
159,231
177,961
339,777
411,207
411,207339,777177,961159,231108,29355,22646,97539,44728,94827,12825,83125,45935,30835,22338,91034,31221,93314,887-12,610-11,336
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
173
335
351
393
382
47,646
26,118
69,614
-357,179
104,433
104,433-357,17969,61426,11847,6463823933513351730000000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue444,401
Cost of Revenue-49,011
Gross Profit395,390395,390
 
Operating Income (+$)
Gross Profit395,390
Operating Expense-164,750
Operating Income230,561230,640
 
Operating Expense (+$)
Research Development6,460
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense164,7506,460
 
Net Interest Income (+$)
Interest Income2,457
Interest Expense-1,088
Other Finance Cost-5
Net Interest Income1,364
 
Pretax Income (+$)
Operating Income230,561
Net Interest Income1,364
Other Non-Operating Income Expenses0
Income Before Tax (EBT)230,360230,762
EBIT - interestExpense = 230,439
230,360
179,755
Interest Expense1,088
Earnings Before Interest and Taxes (EBIT)231,527231,448
Earnings Before Interest and Taxes (EBITDA)251,996
 
After tax Income (+$)
Income Before Tax230,360
Tax Provision-51,693
Net Income From Continuing Ops178,667178,667
Net Income178,667
Net Income Applicable To Common Shares178,667
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses213,761
Total Other Income/Expenses Net-201-1,364
 

Technical Analysis of Chemometec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chemometec. The general trend of Chemometec is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chemometec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ChemoMetec A/S.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 322.80 < 351.60 < 389.00.

The bearish price targets are: 255.00.

Tweet this
ChemoMetec A/S Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ChemoMetec A/S. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ChemoMetec A/S Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ChemoMetec A/S. The current macd is -41.24090148.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chemometec price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Chemometec. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Chemometec price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ChemoMetec A/S Daily Moving Average Convergence/Divergence (MACD) ChartChemoMetec A/S Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ChemoMetec A/S. The current adx is 49.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Chemometec shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
ChemoMetec A/S Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ChemoMetec A/S. The current sar is 333.96.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ChemoMetec A/S Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ChemoMetec A/S. The current rsi is 24.35. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
ChemoMetec A/S Daily Relative Strength Index (RSI) ChartChemoMetec A/S Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ChemoMetec A/S. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chemometec price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ChemoMetec A/S Daily Stochastic Oscillator ChartChemoMetec A/S Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ChemoMetec A/S. The current cci is -112.87865582.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ChemoMetec A/S Daily Commodity Channel Index (CCI) ChartChemoMetec A/S Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ChemoMetec A/S. The current cmo is -60.14644609.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ChemoMetec A/S Daily Chande Momentum Oscillator (CMO) ChartChemoMetec A/S Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ChemoMetec A/S. The current willr is -96.62921348.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ChemoMetec A/S Daily Williams %R ChartChemoMetec A/S Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ChemoMetec A/S.

ChemoMetec A/S Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ChemoMetec A/S. The current atr is 20.73.

ChemoMetec A/S Daily Average True Range (ATR) ChartChemoMetec A/S Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ChemoMetec A/S. The current obv is -412,844.

ChemoMetec A/S Daily On-Balance Volume (OBV) ChartChemoMetec A/S Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ChemoMetec A/S. The current mfi is 16.26.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
ChemoMetec A/S Daily Money Flow Index (MFI) ChartChemoMetec A/S Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ChemoMetec A/S.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

ChemoMetec A/S Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ChemoMetec A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5024.350
Ma 20Greater thanMa 50360.730
Ma 50Greater thanMa 100425.730
Ma 100Greater thanMa 200401.007
OpenGreater thanClose288.200
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chemometec with someone you think should read this too:
  • Are you bullish or bearish on Chemometec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chemometec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ChemoMetec A/S

I send you an email if I find something interesting about ChemoMetec A/S.


Comments

How you think about this?

Leave a comment

Stay informed about ChemoMetec A/S.

Receive notifications about ChemoMetec A/S in your mailbox!